Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase
- PMID: 2840663
- PMCID: PMC281780
- DOI: 10.1073/pnas.85.15.5478
Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase
Abstract
By using oligonucleotide-directed mutagenesis, we have produced a point mutation (guanine to adenine) at nucleotide 388 of the gene for human beta-adrenergic receptor (beta AR) that results in a substitution of asparagine for the highly conserved aspartic acid at position 130 in the putative third transmembrane domain of the human beta AR ([Asn130]beta AR). We have examined the functional significance of this mutation in B-82 cells continuously expressing the mutant [Asn130]beta AR. The mutant [Asn130]beta AR displayed normal antagonist binding but unusually high-affinity agonist binding (5- to 10-fold higher than wild-type beta AR), consistent with a single class of high-affinity binding sites. The mutant beta AR displayed guanine nucleotide-sensitive changes in agonist affinity (3- to 5-fold shift) implying an interaction between the beta AR and the stimulatory guanine nucleotide-binding regulatory protein; however, the ability of guanine nucleotides to alter agonist affinity was attenuated. Addition of saturating concentrations of isoproterenol to cell cultures expressing mutant [Asn130]-beta ARs had no effect on intracellular levels of cAMP, indicating that the mutant beta AR is unable to affect stimulation of adenylate cyclase. These results indicate that substitution of the aspartic acid with asparagine at residue 130 of the human beta AR dissociates the well-characterized guanine nucleotide effects on agonist affinity from those on activation of the stimulatory guanine nucleotide-binding regulatory protein and adenylate cyclase and suggests the existence of two distinct counterions for the amine portion of catecholamines that are associated with high- and low-affinity agonist binding states of beta AR.
Similar articles
-
Site-directed mutagenesis and continuous expression of human beta-adrenergic receptors. Identification of a conserved aspartate residue involved in agonist binding and receptor activation.J Biol Chem. 1988 Mar 25;263(9):4052-5. J Biol Chem. 1988. PMID: 2831218
-
Alterations in the properties of beta-adrenergic receptors of myocardial membranes in aging: impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase.Mech Ageing Dev. 1982 Jun;19(2):127-39. doi: 10.1016/0047-6374(82)90004-5. Mech Ageing Dev. 1982. PMID: 6287123
-
Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.Mol Pharmacol. 1991 Aug;40(2):168-79. Mol Pharmacol. 1991. PMID: 1678850
-
Beta-adrenergic receptors, cyclic AMP, and ion transport in the avian erythrocyte.Adv Cyclic Nucleotide Res. 1975;5:117-32. Adv Cyclic Nucleotide Res. 1975. PMID: 165661 Review.
-
Advances on beta-adrenergic receptors. Molecular structure and functional regulation.Am J Hypertens. 1989 Nov;2(11 Pt 2):252S-256S. doi: 10.1093/ajh/2.11.252s. Am J Hypertens. 1989. PMID: 2554943 Review.
Cited by
-
Molecular biology and respiratory disease. 5. Molecular biology of receptors: implications for lung disease.Thorax. 1990 Jun;45(6):482-8. doi: 10.1136/thx.45.6.482. Thorax. 1990. PMID: 2168097 Free PMC article. Review. No abstract available.
-
Biotechnology of beta-adrenergic receptors.Mol Neurobiol. 1990 Fall-Winter;4(3-4):211-50. doi: 10.1007/BF02780342. Mol Neurobiol. 1990. PMID: 1966919 Review.
-
Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.J Mol Model. 2014 Nov;20(11):2491. doi: 10.1007/s00894-014-2491-2. Epub 2014 Oct 25. J Mol Model. 2014. PMID: 25342155
-
Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium.Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12584-8. doi: 10.1073/pnas.91.26.12584. Proc Natl Acad Sci U S A. 1994. PMID: 7809082 Free PMC article.
-
Structure, function, and regulation of adrenergic receptors.Protein Sci. 1993 Aug;2(8):1198-209. doi: 10.1002/pro.5560020802. Protein Sci. 1993. PMID: 8401205 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials